Immunophenotyping and cytogenetic profile of children with acute lymphoblastic leukemia: A study from a tertiary care center from Kashmir.

  • Faisal R Guru Paediatric Oncology, Sher I Kashmir Institute Of Medical Sciences
  • Nisar ahmad Syed Medical Oncology, Sher I Kashmir Institute Of Medical Sciences
  • Shumail Bashir Government Medical college Baramulla
  • Sanudev sadanandan vp Medical Oncology, Sher I Kashmir Institute Of Medical Sciences
  • Hashim Kunju Ismail Medical Oncology, Sher I Kashmir Institute Of Medical Sciences
  • Gull muhammad Bhat Medical Oncology, Sher I Kashmir Institute Of Medical Sciences
Keywords: ALL, cytogenetics, immunophenotyping, demographic data, pediatric

Abstract

Background

The complete cytogenetic and immunophenotyping data in children suffering from acute lymphoblastic leukemia (ALL) in Jammu and Kashmir is scarce. To bridge this knowledge gap the present study proposes to evaluate the immunophenotype and cytogenetic profile of pediatric ALL patients treated in our hospital.

Material and methods

This hospital-based observational study was conducted on 180 pediatric patients aged between 1  to 18 years who had visited the Paediatric unit of the  Department of Medical Oncology at Sher-I -Kashmir Institute of Medical Science, Srinagar ,Jammu and Kashmir between the January 2015 to December 2019.

Result

Among the study participants, 57.8% were male and 42.2% were female with a mean age of 9.24 years and median of 8 Years. Among the participants, 57.2% were below 10 years of age and 42.8% were above 10years of age. CNS disease was reported in 7.8%  of the study participants.  63.3% patients  had a TLC count of less than 20000. Immunophenotyping data revealed pre-B ALL in 77.8% of children. Cytogenetic study was conducted on 153 patients among them 74.4% had a normal karyotype, 7.2% s had hyperdiploidy and 3.3% had hypodiploidy. The FISH analysis showed that 23.3% of study participants were positive for the TEL-AML study, 11.1% were positive for BCR-ABL analysis and 4.4% of participants were positive for MLL gene analysis. The overall survival in the study population was 78.9% among the study participants. Only the MLL gene rearrangement analysis showed a statistically significant correlation with the survival analysis (P<0.5).

Conclusion

In summary, the present study reported the complete cytogenetic and immunophenotyping profile of the children suffering from acute lymphoblastic leukemia in Jammu and Kashmir.

Downloads

Download data is not yet available.

Author Biographies

Faisal R Guru, Paediatric Oncology, Sher I Kashmir Institute Of Medical Sciences

Assistant Professor

Nisar ahmad Syed, Medical Oncology, Sher I Kashmir Institute Of Medical Sciences

Assistant Professor

Shumail Bashir, Government Medical college Baramulla

Assistant Professor

Sanudev sadanandan vp, Medical Oncology, Sher I Kashmir Institute Of Medical Sciences

DM Scholar

Hashim Kunju Ismail, Medical Oncology, Sher I Kashmir Institute Of Medical Sciences

DM Scholar

Gull muhammad Bhat, Medical Oncology, Sher I Kashmir Institute Of Medical Sciences

Professor and Head

References

1. Sankaranarayanan, R., Ramadas, K. & Qiao, Y. Managing the changing burden of cancer in Asia. BMC Med. 12, 3 (2014).
2. Kumar, D., Panigrahi, M. K., Saikia, K. K., Kapoor, G. & Mehta, A. Molecular analysis of childhood B-acute lymphoblastic leukemia: Identification and prognosis of rare breakpoints. Mol. Biol. 49, 843–847 (2015).
3. PDQ Pediatric Treatment Editorial Board. Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®): Health Professional Version. in PDQ Cancer Information Summaries (National Cancer Institute (US), 2002).
4. Noronha, E. P. et al. The Profile of Immunophenotype and Genotype Aberrations in Subsets of Pediatric T-Cell Acute Lymphoblastic Leukemia. Front. Oncol. 9, 316 (2019).
5. De Marchi, F., Araki, M. & Komatsu, N. Molecular features, prognosis, and novel treatment options for pediatric acute megakaryoblastic leukemia. Expert Rev. Hematol. 12, 285–293 (2019).
6. Siddaiahgari, S., Awaghad, M. & Latha, M. Clinical, immunophenotype and cytogenetic profile of acute lymphoblastic leukemia in children at tertiary health care centre in India. Muller J. Med. Sci. Res. 6, 112 (2015).
7. Padhi, S. et al. Cytogenetic profile of pediatric acute lymphoblastic leukemia (ALL): analysis of 31 cases with review of literature. Caryologia 64, 33–41 (2011).
8. Khalid, S., Moiz, B., Adil, S. N. & Khurshid, M. Retrospective review of pediatric patients with acute lymphoblastic leukemia: a single center experience. Indian J. Pathol. Microbiol. 53, 704 (2010).
9. Alkhayat, N. et al. Cytogenetic Profile and FLT3 Gene Mutations of Childhood Acute Lymphoblastic Leukemia. Clin. Med. Insights Oncol. 11, 117955491772171 (2017).
10. Gupta, N. et al. FxCycleTM Based Ploidy Correlates with Cytogenetic Ploidy in B-Cell Acute Lymphoblastic Leukemia and Is Able to Detect the Aneuploid Minimal Residual Disease Clone. Cytometry B Clin. Cytom. 96, 359–367 (2019).
11. Wang, Y. M., Mo, J. Q., Kuo, D. J. & Wong, V. MLL rearranged acute lymphoblastic leukaemia presenting as a maxillary sinus mass with a discordant immunophenotypic profile from the bone marrow. BMJ Case Rep. CP 12, (2019).
12. Smith, M. C., Kressin, M. K., Crawford, E., Wang, X. J. & Kim, A. S. B Lymphoblastic Leukemia With a Novel t(11;15) (q23;q15) and Unique Burkittoid Morphologic and Immunophenotypic Findings in a 9-Year-Old Boy. Lab. Med. 46, 320–326 (2015).
13. Amare, P. S. K. et al. Cytogenetic Profile in 7209 Indian Patients with de novo Acute Leukemia: A Single Centre Study from India. J. Cancer Ther. 7, 530–544 (2016).
Published
2020-06-22
How to Cite
1.
Guru F, Syed N, Bashir S, vp S, Ismail H, Bhat G. Immunophenotyping and cytogenetic profile of children with acute lymphoblastic leukemia: A study from a tertiary care center from Kashmir. jms [Internet]. 2020Jun.22 [cited 2026Oct.2];23(2):32-9. Available from: http://ano.jmsskims.org/index.php/jms/article/view/508
Section
Original Articles